Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

163 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

NCT02593188

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Kern Allergy Medical Clinic Bakersfield, California, United States
  • University of California Irvine Medical Center Irvine, California, United States
  • Riviera Allergy Medical Center Redondo Beach, California, United States
  • Capital Allergy & Respiratory Disease Center Sacramento, California, United States
View all 30 locations
View Trial Details
Completed

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

NCT03815357

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, IRAK4 Deficiency, +7 more
Locations
  • Sydney Children's Hospital Sydney, New South Wales, Australia
  • Adelaide Women's and Children's Hospital Adelaide, South Australia, Australia
  • Monash Health Clayton, Victoria, Australia
  • Royal Children's Hospital Melbourne, Victoria, Australia
View Trial Details
Completed

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

NCT02269163

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of California, Irvine Irvine, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Immunoe International Research Centennial, Colorado, United States
  • National Jewish Hospital Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

NCT00157079

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +30 more
Locations
  • Children´s Hospital Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • 1st Allergy and Clinical Research Center Englewood, Colorado, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
View Trial Details
Completed

Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)

NCT00161993

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Tampere University Hospital Tampere, Finland
  • Turku University Central Hospital Turku, Finland
  • SU/Sahlgrenska Gothenburg, Sweden
  • University Hospital Lund Lund, Sweden
View Trial Details
Completed

Study of Octanorm Subcutaneous IG in Patients With PID

NCT01888484

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Octapharma Research Site Birmingham, Alabama, United States
  • Octapharma Research Site Irvine, California, United States
  • Octapharma Research Site San Diego, California, United States
  • Octapharma Research Site Centennial, Colorado, United States
View all 24 locations
View Trial Details
Completed

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

NCT00919503

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +51 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details

Related conditions